发明名称 |
Topical drug delivery systems for ophthalmic use |
摘要 |
<p>Topical drug delivery systems for ophthalmic use including mixed nanomicellar formulations of water-insoluble drugs and methods of treating diseases affecting the posterior ocular segments are disclosed. In an embodiment, an aqueous ophthalmic solution includes nanomicelles in a physiologically acceptable buffer, having a pH of 5.0 to 8.0, wherein a corticosteroid at a concentration from about 0.01 % w/v to about 1.00 % w/v is solubilized through entrapment in a mixed micellar hydrophobic core with a corona composed of hydrophilic chains extending from the hydrophobic core, wherein the nanomicelles comprise vitamin E TPGS at a concentration ranging from about 3.0 % w/v to about 5.0 % w/v stabilized with octoxynol-40 at a concentration ranging from about 1.0 % w/v to about 3.0 % w/v.</p> |
申请公布号 |
AU2010259184(B2) |
申请公布日期 |
2015.08.13 |
申请号 |
AU20100259184 |
申请日期 |
2010.05.05 |
申请人 |
AURINIA PHARMACEUTICALS, INC. |
发明人 |
MITRA, ASHIM K.;VELAGALETI, POONAM R.;GRAU, ULRICH M. |
分类号 |
A61K9/14 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|